Qureight secures $20 million in Series B funding, led by Molten Ventures. The financing will aid in the expansion of its 3D deep learning imaging technologies for clinical trials.
Amount Raised
$20 Million
Round Type
Series B
CambridgeSoftwareHealth CareInvestors
Description
Qureight, a company specializing in imaging for clinical trials focused on lung and heart disease, has closed a $20 million Series B financing. The round was led by Molten Ventures, with participation from existing investors including Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension. The new funds will support the company's expansion efforts. This financing marks a significant step for Qureight in enhancing its technological capabilities.
Who else raised in Software and Health Care around the same time
Companies in the same sectors as Qureight that raised within 45 days of this round, from Fundz verified event records.
Who to call at Qureight, and when
A new round usually means Qureight is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Qureight raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Qureight, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Qureight. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Qureight raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansQureight raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.